Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
5 clinical trials · Condition
◉ Watch Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
| Record | Firm | Date |
|---|---|---|
| LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib (NCT04216121) | Universitaire Ziekenhuizen KU Leuven | 2021-05-10 |
| HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer (NCT04619004) | Daiichi Sankyo | 2021-02-02 |
| Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC (NCT04141644) | University of Utah | 2020-08-20 |
| Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer (NCT06207292) | Radiotherapy Oncology Centre "Santa Maria" Hospital | 2016-12-01 |
Track Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor automatically
Every clearance here is in the API, with alerts when new ones post.